Sjogren’s Syndrome CD3+ T Cells
About: Sjogren’s Syndrome CD3 T Cells are from clinically confirmed Sjogren’s donors. These samples support research on exocrine gland infiltration and aberrant T cell activation in autoimmune damage.
Sjogren’s Syndrome CD3 T Cells for Autoimmune and Immunopathology Research
Sjogren’s Syndrome CD3 T Cells are isolated from peripheral blood of IRB-consented adult donors diagnosed with Sjogren’s Syndrome. These CD3+ T lymphocytes reflect the immune dysfunction associated with Sjogren’s Syndrome and are valuable for investigating T cell phenotypes, cytokine secretion, exhaustion, and inflammation in autoimmunity and chronic disease.
Product Features
- Research Use Only (RUO), CD3+ enriched T cells
- Isolated from clinically confirmed Sjogren’s Syndrome donors
- High viability and CD3+ cell enrichment
- Cryopreserved in CryoStor® CS10 media
- Processed within 24 hours of collection
- IRB-approved collection and HIPAA-compliant handling
De-identified Donor Data
- Confirmed Sjogren’s Syndrome diagnosis
- Demographics: age, sex assigned at birth, race/ethnicity
- Clinical history and medication records available
Applications
- T cell subset analysis and immune profiling in Sjogren’s Syndrome
- Autoimmunity, exhaustion, and cytokine production studies
- Target validation and preclinical drug development
- Cell therapy and immune modulation modeling
Compliance and Quality Assurance
- IRB-approved protocols and 21 CFR Part 11–compliant e-consent
- Standardized isolation and cryopreservation
- HIPAA-compliant data protection and donor confidentiality
Ordering & Customization
Sjogren’s Syndrome CD3 T Cells are available in standard or custom aliquot sizes. For international shipments or documentation, contact learnmore@sanguinebio.com.
Protocols & Documentation
-
Download
Immune Cell Isolation
Guidelines for isolating immune cell populations with validated enrichment steps, purity checkpoints, and documentation.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
CD3+ T Cells
Frequently Asked Questions
1 Answer
All our samples have self-reported infectious disease testing and verified clinical diagnosis. Many of our samples have the option of electronic medical records provided and our prospective collection offers the opportunity for patient reported outcomes and surveys. Learn more here. https://sanguinebio.com/patient-reported-outcomes-pro-surveys-questionnaires/
1 Answer
YES – Certificate of analysis is available upon request.
1 Answer
Lead times vary from ready to ship inventory to prospective studies.
1 Answer
International shipping is available. We also work with a number of distributors. Contact us to discuss options at learnmore@sanguinebio.com.
1 Answer
We have several ordering methods. You can order directly online with a PO or credit card or contact us to have a sales specialist help with your order. https://sanguinebio.com/request-quote/
1 Answer
You can request a quote on this page or contact us at learnmore@sanguinebio.com. https://sanguinebio.com/request-quote/
1 Answer
NO – no minimum order requirements.
1 Answer
For bulk pricing inquiries, please contact: LearnMore@sanguinebio.com
1 Answer
YES – All three cell types are available.
Ask a Question
Need a custom CD3+ T Cells cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.